Search research articles
Contact Us
Filters
Showing results (551-560 of 667) with videos related to
Page
of 67
Sort By:
Cancer Cell
|
November 11, 2022
Challenges in neoantigen-directed therapeutics
Lien Lybaert, Steve Lefever, Bruno Fant, et al.
Plos One
|
January 6, 2011
A phase II trial of sorafenib in metastatic melanoma with tissue correlates
Patrick A Ott, Anne Hamilton, Christina Min, et al.
Oncology
|
June 12, 2017
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care
Chloe Goldman, Jeremy Tchack, Eric M Robinson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 3, 2017
Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy
Andrew Bang, Tyler J Wilhite, Luke R G Pike, et al.
Immunogenetics
|
April 21, 2023
Evolution of immunogenetic components encoding ultralong CDR H3
Jeannine A Ott, Christian Mitchell, Morgan Sheppard, et al.
Neurology
|
March 24, 2004
Effect of smoking on global cognitive function in nondemented elderly
A Ott, K Andersen, M E Dewey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2017
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial
Jean-Sebastien Frenel, Christophe Le Tourneau, Bert O'Neil, et al.
Investigational New Drugs
|
August 7, 2012
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Patrick A Ott, Richard D Carvajal, Neeta Pandit-Taskar, et al.
Alimentary Pharmacology & Therapeutics
|
May 11, 2005
Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial
E A Ott, L E Mazzoleni, M I Edelweiss, et al.
Journal for Immunotherapy of Cancer
|
November 9, 2019
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
Marieke J Krimphove, Karl H Tully, David F Friedlander, et al.
Page
of 67
Search research articles
Search
Showing results (551-560 of 667) with videos related to
Sort By:
Page
of 67
Cancer Cell
|
November 11, 2022
Challenges in neoantigen-directed therapeutics
Lien Lybaert, Steve Lefever, Bruno Fant, et al.
Plos One
|
January 6, 2011
A phase II trial of sorafenib in metastatic melanoma with tissue correlates
Patrick A Ott, Anne Hamilton, Christina Min, et al.
Oncology
|
June 12, 2017
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care
Chloe Goldman, Jeremy Tchack, Eric M Robinson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 3, 2017
Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy
Andrew Bang, Tyler J Wilhite, Luke R G Pike, et al.
Immunogenetics
|
April 21, 2023
Evolution of immunogenetic components encoding ultralong CDR H3
Jeannine A Ott, Christian Mitchell, Morgan Sheppard, et al.
Neurology
|
March 24, 2004
Effect of smoking on global cognitive function in nondemented elderly
A Ott, K Andersen, M E Dewey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2017
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial
Jean-Sebastien Frenel, Christophe Le Tourneau, Bert O'Neil, et al.
Investigational New Drugs
|
August 7, 2012
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Patrick A Ott, Richard D Carvajal, Neeta Pandit-Taskar, et al.
Alimentary Pharmacology & Therapeutics
|
May 11, 2005
Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial
E A Ott, L E Mazzoleni, M I Edelweiss, et al.
Journal for Immunotherapy of Cancer
|
November 9, 2019
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
Marieke J Krimphove, Karl H Tully, David F Friedlander, et al.
Page
of 67